Humana reported $137.2B of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $137.2B (to Q1 2026). Net income: $1.13B, trailing twelve months to Q1 2026. Free cash flow: $1.27B, trailing twelve months to Q1 2026. Operating margin: 1.6%, trailing twelve months to Q1 2026.

HUMHumana

Healthcare

$431.00+65% 1Y

$431.00

$162.8452 weeks$443.49

HUM as reported

Humana reported $137.2B of revenue over the trailing twelve months, +14% on the year before. 10 reported series are charted on this page, each one as filed.

$137.2B

Revenue, trailing twelve months · to Q1 2026 · +14% against the twelve months before

Net income: $1.13B
Net income · −34% year on year · trailing twelve months to Q1 2026
Free cash flow: $1.27B
Free cash flow · −47% year on year · trailing twelve months to Q1 2026
Operating margin: 1.6%
Operating margin · trailing twelve months to Q1 2026

Details›

Every series Ryufin has for HUM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$137.2B	+14%	Q1 2026
Net income	$1.13B	−34%	Q1 2026
EPS	$9.37	−34%	Q1 2026
Operating margin	1.6%	n/a	Q1 2026
Net margin	0.71%	n/a	Q1 2026
ROE	7.1%	n/a	Q1 2026
ROA	2.5%	n/a	Q1 2026
ROIC	23%	n/a	Q1 2026
Free cash flow	$1.27B	−47%	Q1 2026
P/E	46.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.